Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,789,059 | 2,127,300 | 1,389,762 | 647,303 | 2,889,749 |
| Depreciation Amortization | 302,232 | 228,807 | 155,806 | 80,914 | 265,477 |
| Income taxes - deferred | 64,061 | 43,415 | 40,008 | 20,546 | 12,152 |
| Accounts receivable | -375,736 | -221,393 | -221,966 | -107,876 | -348,875 |
| Accounts payable and accrued liabilities | 428,944 | 257,805 | 295,648 | 176,114 | -4,453 |
| Other Working Capital | 211,853 | 72,128 | 74,978 | 31,677 | -680,380 |
| Other Operating Activity | 218,597 | 152,841 | 29,561 | -28,136 | 700,243 |
| Operating Cash Flow | $3,639,010 | $2,660,903 | $1,763,797 | $820,542 | $2,833,913 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,310,357 | -156,089 | -140,058 | -64,406 | -1,784,867 |
| PPE Investments | -131,904 | -105,794 | -41,505 | -14,870 | -61,884 |
| Net Acquisitions | -588,608 | -588,608 | -588,608 | -221,105 | -91,000 |
| Investing Cash Flow | $3,589,845 | $-850,491 | $-770,171 | $-300,381 | $-1,937,751 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,696,850 | 987,370 | 987,370 | 987,370 | 2,962,500 |
| Debt Repayment | -687,697 | -651,606 | -651,554 | -1,533 | -868,408 |
| Common Stock Issued | 211,737 | 158,234 | 115,912 | 58,879 | 376,648 |
| Common Stock Repurchased | -2,383,132 | -2,156,830 | -1,272,862 | -548,699 | -4,022,593 |
| Other Financing Activity | -74,189 | -100,219 | -65,718 | -10,907 | 213,143 |
| Financing Cash Flow | $1,763,569 | $-1,763,051 | $-886,852 | $485,110 | $-1,338,710 |
| Exchange Rate Effect | -16,526 | -45,881 | -108,874 | -77,172 | 77,469 |
| Beginning Cash Position | 907,879 | 907,879 | 907,879 | 907,879 | 1,272,958 |
| End Cash Position | 9,883,777 | 909,359 | 905,779 | 1,835,978 | 907,879 |
| Net Cash Flow | $8,975,898 | $1,480 | $-2,100 | $928,099 | $-365,079 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,639,010 | 2,660,903 | 1,763,797 | 820,542 | 2,833,913 |
| Capital Expenditure | -131,904 | -105,794 | -41,505 | -14,870 | -61,884 |
| Free Cash Flow | 3,507,106 | 2,555,109 | 1,722,292 | 805,672 | 2,772,029 |